TSM [TAIWAN SEMICONDUCTOR MANUFACTURING CO] 6-K: (Original Filing)

[Taiwan Semiconductor Manufacturing Company Ltd. By Lora Ho Senior Vice President & Chief Financial Officer Taiwan Semiconductor Manufacturing Company Limited 1) The changes in the shareholdings of our board directors, executive officers and shareholders who own more than 10% of total outstanding common shares:]

By | 2016-03-12T22:53:07+00:00 November 25th, 2014|Categories: Chinese Stocks, SEC Original, TSM|Tags: , , , , , |0 Comments

KANG [iKang Healthcare] 6-K: (Original Filing)

[IKANG ANNOUNCES UNAUDITED FINANCIAL RESULTS FOR FISCAL SECOND QUARTER ENDED SEPTEMBER 30, 2014 BEIJING, November 24, 2014 (GLOBE NEWSWIRE) — iKang Healthcare Group, Inc. (“iKang” or the “Company”) (Nasdaq: KANG), the largest provider in China’s fast growing private preventive healthcare services market in terms of revenue in 2013, today announced its unaudited financial results for the fiscal second quarter ended] [FORM 6-K IKANG HEALTHCARE GROUP, INC. B-6F, Shimao Tower 92A Jianguo Road Chaoyang District, Beijing 100022 People’s Republic of China Form 20-F x Form 40-F o o o IKANG HEALTHCARE GROUP, INC.]

TSM [TAIWAN SEMICONDUCTOR MANUFACTURING CO] 6-K: Taiwan Semiconductor Manufacturing Company Ltd. By Lora Ho

[Taiwan Semiconductor Manufacturing Company Ltd. By Lora Ho Senior Vice President & Chief Financial Officer Taiwan Semiconductor Manufacturing Company Limited 1) The changes in the shareholdings of our board directors, executive officers and shareholders who own more than 10% of total outstanding common shares:]

By | 2016-03-12T22:56:03+00:00 November 25th, 2014|Categories: Chinese Stocks, TSM, Webplus ver|Tags: , , , , , |0 Comments

KANG [iKang Healthcare] 6-K: IKANG ANNOUNCES UNAUDITED FINANCIAL RESULTS FOR FISCAL SECOND

[IKANG ANNOUNCES UNAUDITED FINANCIAL RESULTS FOR FISCAL SECOND QUARTER ENDED SEPTEMBER 30, 2014 BEIJING, November 24, 2014 (GLOBE NEWSWIRE) — iKang Healthcare Group, Inc. (“iKang” or the “Company”) (Nasdaq: KANG), the largest provider in China’s fast growing private preventive healthcare services market in terms of revenue in 2013, today announced its unaudited financial results for the fiscal second quarter ended] [FORM 6-K IKANG HEALTHCARE GROUP, INC. B-6F, Shimao Tower 92A Jianguo Road Chaoyang District, Beijing 100022 People’s Republic of China Form 20-F x Form 40-F o o o IKANG HEALTHCARE GROUP, INC.]

QIHU [Qihoo 360 Technology Co] 6-K: (Original Filing)

[Qihoo 360 Reports Third Quarter 2014 Unaudited Financial Results Qihoo 360 Technology Co. Ltd. BEIJING, November 24, 2014 -- (1) Third Quarter Financial Highlights l Revenues were $376.4 million, a 100.3% increase from $187.9 million in the third quarter of 2013. l Net income attributable to Qihoo 360 was $57.7 million, compared to $44.5 million in the third quarter of] []

By | 2016-03-13T23:36:56+00:00 November 25th, 2014|Categories: Chinese Stocks, QIHU, SEC Original|Tags: , , , , , |0 Comments

CO [China Cord Blood] 6-K: (Original Filing)

[China Cord Blood Corporation Reports Financial Results for the Second Quarter and First Half of Fiscal 2015 2Q15 Added 15,584 New Subscribers 2Q15 Revenue Up 7.4% YOY to RMB152.1 Million ($24.8 Million) 2Q15 Operating Income Increased to RMB57.5 Million ($9.4 Million) Conference Call to be Held November 26, 2014 at 8:00 a.m. ET HONG KONG, China, November 25, 2014 –] [EXPLANATORY NOTE Results of Operations and Financial Condition Following this cover page are the preliminary unaudited condensed consolidated financial results for the three months and six months ended September 30, 2014 of the Company. CHINA CORD BLOOD CORPORATION UNAUDITED CONDENSED CONSOLIDATED BALANCE SHEETS As of March 31 and September 30, 2014]

By | 2016-03-27T09:32:41+00:00 November 25th, 2014|Categories: Chinese Stocks, CO, SEC Original|Tags: , , , , , |0 Comments

QIHU [Qihoo 360 Technology Co] 6-K: Qihoo 360 Reports Third Quarter 2014 Unaudited Financial

[Qihoo 360 Reports Third Quarter 2014 Unaudited Financial Results Qihoo 360 Technology Co. Ltd. BEIJING, November 24, 2014 -- (1) Third Quarter Financial Highlights l Revenues were $376.4 million, a 100.3% increase from $187.9 million in the third quarter of 2013. l Net income attributable to Qihoo 360 was $57.7 million, compared to $44.5 million in the third quarter of] []

By | 2016-03-13T23:38:08+00:00 November 25th, 2014|Categories: Chinese Stocks, QIHU, Webplus ver|Tags: , , , , , |0 Comments

CO [China Cord Blood] 6-K: China Cord Blood Corporation Reports Financial Results for

[China Cord Blood Corporation Reports Financial Results for the Second Quarter and First Half of Fiscal 2015 2Q15 Added 15,584 New Subscribers 2Q15 Revenue Up 7.4% YOY to RMB152.1 Million ($24.8 Million) 2Q15 Operating Income Increased to RMB57.5 Million ($9.4 Million) Conference Call to be Held November 26, 2014 at 8:00 a.m. ET HONG KONG, China, November 25, 2014 –] [EXPLANATORY NOTE Results of Operations and Financial Condition Following this cover page are the preliminary unaudited condensed consolidated financial results for the three months and six months ended September 30, 2014 of the Company. CHINA CORD BLOOD CORPORATION UNAUDITED CONDENSED CONSOLIDATED BALANCE SHEETS As of March 31 and September 30, 2014]

By | 2016-03-27T09:34:14+00:00 November 25th, 2014|Categories: Chinese Stocks, CO, Webplus ver|Tags: , , , , , |0 Comments

OIIM [O2MICRO INTERNATIONAL] SC 13D: (Original Filing)

[JOINT FILING AGREEMENT Dated: November 24, 2014 Lone Star Value Investors, LP Lone Star Value Investors GP, LLC General Partner Jeffrey E. Eberwein Manager Lone Star Value Investors GP, LLC Jeffrey E. Eberwein Manager Lone Star Value Management, LLC] []

By | 2016-03-28T03:38:12+00:00 November 25th, 2014|Categories: Chinese Stocks, OIIM, SEC Original|Tags: , , , , , |0 Comments
Skip to toolbar